ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
CorMedix Inc

CorMedix Inc (CRMD)

8.90
0.00
( 0.00% )
Updated: 19:00:00

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
8.90
Bid
-
Ask
-
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Market Cap
Previous Close
8.90
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
-
Shares Outstanding
54,812,000
Dividend Yield
-
PE Ratio
-9.63
Earnings Per Share (EPS)
-0.85
Revenue
-
Net Profit
-46.34M

About CorMedix Inc

Cormedix Inc is a biopharmaceutical company that focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. It has been in-licensed to develop and commercialize Neutrolin, which is a novel anti-infective solution for the r... Cormedix Inc is a biopharmaceutical company that focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. It has been in-licensed to develop and commercialize Neutrolin, which is a novel anti-infective solution for the reduction and prevention of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical settings such as hemodialysis, total parenteral nutrition, and oncology. The Neutrolin product is designed to target unmet medical needs. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Wilmington, Delaware, USA
Founded
-

CRMD Latest News

CorMedix Inc. to Begin Trading on the Nasdaq Stock Exchange

BERKELEY HEIGHTS, N.J., Jan. 21, 2021 (GLOBE NEWSWIRE) -- CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the...

CorMedix Inc. Announces FDA Decision That Advisory Committee Meeting for New Drug Application for Defencath is Not Needed

PDUFA date remains February 28, 2021Potentially the first antibacterial and antifungal catheter lock solution in the US to prevent catheter related infections in hemodialysis patients BERKELEY...

CorMedix Inc. Reports Third Quarter 2020 Financial Results and Provides Business Update

BERKELEY HEIGHTS, N.J., Nov. 05, 2020 (GLOBE NEWSWIRE) -- CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the...

CorMedix Appoints Greg Duncan to its Board of Directors

BERKELEY HEIGHTS, N.J., Nov. 02, 2020 (GLOBE NEWSWIRE) -- CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the...

CorMedix to Participate in BIO Investor Forum Digital

BERKELEY HEIGHTS, N.J., Oct. 08, 2020 (GLOBE NEWSWIRE) -- CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the...

CorMedix Appoints Paulo Costa to its Board of Directors

BERKELEY HEIGHTS, N.J., Sept. 17, 2020 (GLOBE NEWSWIRE) -- CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the...

CorMedix Inc. to Present at the H.C. Wainwright 22nd Annual Global Investment Conference

BERKELEY HEIGHTS, N.J., Sept. 09, 2020 (GLOBE NEWSWIRE) -- CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the...

CorMedix Inc. Announces FDA Acceptance for Filing and Priority Review of New Drug Application for Defencath

FDA sets PDUFA goal date of February 28, 2021Potentially the first antibacterial and antifungal catheter lock solution in the US to prevent catheter related infections in hemodialysis patients ...

CorMedix Inc. Reports Second Quarter and Six Month 2020 Financial Results and Provides Business Update

BERKELEY HEIGHTS, N.J., Aug. 10, 2020 (GLOBE NEWSWIRE) -- CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the...

CorMedix Announces Pricing of $20M Public Offering of Common Stock

BERKELEY HEIGHTS, N.J., July 28, 2020 (GLOBE NEWSWIRE) -- CorMedix Inc. (NYSE American: CRMD) (the “Company”), a biopharmaceutical company focused on developing and commercializing therapeutic...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

CRMD - Frequently Asked Questions (FAQ)

What is the current CorMedix share price?
The current share price of CorMedix is $ 8.90
How many CorMedix shares are in issue?
CorMedix has 54,812,000 shares in issue
What is the market cap of CorMedix?
The market capitalisation of CorMedix is USD 487.83M
What is the 1 year trading range for CorMedix share price?
CorMedix has traded in the range of $ 0.00 to $ 0.00 during the past year
What is the PE ratio of CorMedix?
The price to earnings ratio of CorMedix is -9.63
What is the reporting currency for CorMedix?
CorMedix reports financial results in USD
What is the latest annual profit for CorMedix?
The latest annual profit of CorMedix is USD -46.34M
What is the registered address of CorMedix?
The registered address for CorMedix is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the CorMedix website address?
The website address for CorMedix is www.cormedix.com
Which industry sector does CorMedix operate in?
CorMedix operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CTMCastellum Inc
$ 2.5502
(79.59%)
52.17M
OPTTOcean Power Technologies Inc
$ 0.7866
(64.97%)
202.12M
SATXSatixFy Communications Ltd
$ 1.91
(54.84%)
1.84M
BURUNuburu Inc
$ 0.83
(45.36%)
14.02M
LODEComstock Inc
$ 0.9645
(39.34%)
39.43M
MINFT Limited
$ 4.15
(-35.16%)
273.83k
CNBSAmplify Seymour Cannabis ETF
$ 1.86
(-33.33%)
143.83k
CVMCel Sci Corporation New
$ 0.4062
(-32.31%)
7.73M
GRFXGraphex Group Limited
$ 0.3201
(-26.41%)
1.66M
XTRGlobal X S&P 500 Tail Risk ETF
$ 27.51
(-17.56%)
23.64k
OPTTOcean Power Technologies Inc
$ 0.7866
(64.97%)
202.68M
UVIX2x Long VIX Futures ETF
$ 3.2199
(0.94%)
56M
SPXSDirexion Daily S&P 500 Bear 3X Shares New
$ 6.1101
(1.84%)
54.83M
CTMCastellum Inc
$ 2.5502
(79.59%)
52.64M
SOXLDirexion Daily Semiconductor Bull 3X Shares
$ 28.595
(-3.69%)
47.27M

Discussion

View Full Feed
PENNY PIRATE PENNY PIRATE 3 minutes ago
gitreal ... Fail? No, Obviously the Tailings Plan is in Place or there would Not have been a Permit given for the Processing Facility in the First Place! I've Shown Various Options, there are others, and as you already know, Technology has Gained Traction in this Field and there are a Variety of Opt
AABB
TrendTrade2016 TrendTrade2016 3 minutes ago
BLBX MONSTER
BLBX
Budots Budots 3 minutes ago
$CBDW 1606 Corp. Expresses Strong Support for Adnexus Biotechnologies' Groundbreaking AI Technology https://finance.yahoo.com/news/1606-corp-expresses-strong-support-130000211.html
CBDW
somberfox somberfox 3 minutes ago
Dunno. Guess we may or may not know in January or something.
CLNV
StockItOut StockItOut 3 minutes ago
Which one's? Cite them.

(You do as you demand, don't you?)

And what about your cited case shows to undo Basile's NY cases?
XERI
Budots Budots 3 minutes ago
$CBDW 1606 Corp. Expresses Strong Support for Adnexus Biotechnologies' Groundbreaking AI Technology https://finance.yahoo.com/news/1606-corp-expresses-strong-support-130000211.html
CBDW
TURCH TURCH 3 minutes ago
🤬 thx

Not sure how i didnt see that one uggh too many tickers lol

Regards
Duke Knockem Duke Knockem 3 minutes ago
Seems like sharp and the other insider held 43M Shares. I'm curious if those are still possible to cancel or it's too late. I think 70M Shares total could be cancelled looking at the last fillings. Seems like previous management dumped big towards the end.
ENCC
benhor benhor 3 minutes ago
$IDAI just like predicted stock just hit dollar land and going super strong 

1.0396 +0.3296 46.42%
IDAI
Number sleven Number sleven 3 minutes ago
RMB, That is what Amarin is attempting to do. Recently we lost CVS after a failed negotiation. Interestingly our CEO was gone soon after. If you are going to say that Amarin is loosing prescriptions, show the numbers. We have more than 50% of the US market. Do you think we have achieved this by char
API CVS PBM
tw0122 tw0122 3 minutes ago
The drones are busy $20.02 +20%
UMAC
BasedOnFeels BasedOnFeels 3 minutes ago
This was GM's personal guarantee on his assets upon default, read the lease agreement and complaint and judgement.. Nick Augustino is free and clear and so is GRLT. Null and void once this happens. The landlord didnt go for anything other than GMs assets, because GM allowed him to and the judge sign
GRLT
JusDePomme JusDePomme 4 minutes ago
Minh moi mua vao! How r ya?
AFFU
gp22 gp22 4 minutes ago
$BKYI: Bio-Key AI Inc....This one is the last USA AI Drone play...Its going and its going to be GONE....$10.00+
BKYI
ANTI-BAGHOLDER ANTI-BAGHOLDER 4 minutes ago
You still holding a massive bag when it was obvious you were throwing money away?
TGGI
Konaploinks Konaploinks 4 minutes ago
I’d like to see the look on Elon’s face when he reads these 2 new pr’s out today. He’s gonna call Trump and say yep Mr President it’s been proven. We’re going to save the country trillions! All across every sector of the government, we can optimize everything now. Ionq quantum computers can have a
IONQ
jimr1717 jimr1717 4 minutes ago
Perhaps the Ozone-Saver3000 © would work for the "Hutchinsons Effect," as well.

I will add this future (2097) potential revenue stream to the already 96,842 SINT future revenue streams to my page.
When you have 3 or 4 days of reading time please check out my page with all
SINT
getmoreshares getmoreshares 4 minutes ago
Financial Volume $ 55
MRNJ
Edward Edward 4 minutes ago
BZWR is finished as a company. The only thing that may save it is the assumed merger. However the company that is BZWR planned to merge with is just as bab.

They should just declare CH.11.

It will be a very long time for them to get out of the Expert market, IF EVER.
BZWR
Big Hook Big Hook 4 minutes ago
Some people like using the word scam and don’t realize that today’s technology makes it very hard to hide. Slander isn’t funny!
HMBL
georgie18 georgie18 4 minutes ago
SGLY...$1.66...🥳...Psar flipped Bullish today...

georgie18

Member Level
Re: georgie18 post# 667789

Friday, December 27, 2024 3:12:34 PM

Post#
669293
of 669634
SGLY...$1.55...🥳Trying to Reverse
SGLY
georgie18 georgie18 5 minutes ago
SGLY...$1.66...🥳...Psar flipped Bullish today...

georgie18

Member Level
Re: georgie18 post# 667789

Friday, December 27, 2024 3:12:34 PM

Post#
669293
of 669634
SGLY...$1.55...🥳Trying to Reverse
SGLY
236T568 236T568 5 minutes ago
Those big employers

https://bsky.app/profile/cwebbonline.com/post/3leigb6ig422v
tuzedaze tuzedaze 5 minutes ago
Sammy… Been following you a long time…. You are pretty spot on with predictions…. How did you play this mornings price action? Curious of your strategy…
FMCC
georgie18 georgie18 5 minutes ago
SGLY...$1.66...🥳...Psar flipped Bullish today...

georgie18

Member Level
Re: georgie18 post# 667789

Friday, December 27, 2024 3:12:34 PM

Post#
669293
of 669634
SGLY...$1.55...🥳Trying to Reverse
SGLY